Jufang Wu

12 Middle Wulumuqi Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Intrapulmonary pharmacokinetics and safety of eravacycline in critically ill patients with HAP/VAP caused by carbapenem-resistant Acinetobacter baumannii and Enterobacterales: a prospective study.

Intrapulmonary pharmacokinetics and safety of eravacycline in critically ill patients with HAP/VAP caused by carbapenem-resistant Acinetobacter baumannii and Enterobacterales: a prospective study.

Journal: International journal of antimicrobial agents

Published: May 15, 2026

Limited association between serum vancomycin pharmacokinetic/ pharmacodynamic indices and clinical outcomes in gram-positive complicated urinary tract infections.

Limited association between serum vancomycin pharmacokinetic/ pharmacodynamic indices and clinical outcomes in gram-positive complicated urinary tract infections.

Journal: Frontiers in pharmacology

Published: December 20, 2025

Effect of itraconazole on pharmacokinetics of ZX-7101A tablets in healthy Chinese subjects.

Effect of itraconazole on pharmacokinetics of ZX-7101A tablets in healthy Chinese subjects.

Journal: Frontiers in pharmacology

Published: October 13, 2025

Pharmacokinetics of Nirmatrelvir/Ritonavir after Multiple Administration in a Phase 1, Open-Label Study in Healthy Chinese Adults and Compared with Non-Chinese Participants.

Pharmacokinetics of Nirmatrelvir/Ritonavir after Multiple Administration in a Phase 1, Open-Label Study in Healthy Chinese Adults and Compared with Non-Chinese Participants.

Journal: Clinical drug investigation

Published: September 30, 2025

Pharmacokinetics of Aztreonam-Avibactam After Single- and Multiple-Dose Administration: A Phase 1, Open-Label Study in Healthy Chinese Participants and Ethnic Comparison with Non-Chinese Participants.

Pharmacokinetics of Aztreonam-Avibactam After Single- and Multiple-Dose Administration: A Phase 1, Open-Label Study in Healthy Chinese Participants and Ethnic Comparison with Non-Chinese Participants.

Journal: Clinical pharmacology in drug development

Published: August 14, 2025

Development and Validation of a Rapid LC-MS/MS Method for Quantifying Eravacycline in Epithelial Lining Fluid: Application to a Prospective Pulmonary Distribution Study in HAP/VAP Patients.

Development and Validation of a Rapid LC-MS/MS Method for Quantifying Eravacycline in Epithelial Lining Fluid: Application to a Prospective Pulmonary Distribution Study in HAP/VAP Patients.

Journal: Antibiotics (Basel, Switzerland)

Published: August 06, 2025

Population pharmacokinetics/pharmacodynamics of eravacycline in patients with complicated intra-abdominal infections and community acquired bacterial pneumonia: Support for a fixed-dose treatment regimen.

Population pharmacokinetics/pharmacodynamics of eravacycline in patients with complicated intra-abdominal infections and community acquired bacterial pneumonia: Support for a fixed-dose treatment regimen.

Journal: International journal of antimicrobial agents

Published: May 06, 2025

A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults.

A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults.

Journal: Clinical pharmacology in drug development

Published: April 17, 2025

Erratum for Yang et al., "A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects".

Erratum for Yang et al., "A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects".

Journal: Antimicrobial agents and chemotherapy

Published: September 12, 2024

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia.

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia.

Journal: Frontiers in pharmacology

Published: June 29, 2024

Pharmacokinetics and safety of EVER206, a novel polymyxin antimicrobial, in healthy Chinese subjects.

Pharmacokinetics and safety of EVER206, a novel polymyxin antimicrobial, in healthy Chinese subjects.

Journal: Antimicrobial agents and chemotherapy

Published: April 22, 2024

Age-Related Differences in Vancomycin-Associated Nephrotoxicity and Efficacy in Methicillin-Resistant Staphylococcus aureus Infection: A Comparative Study between Elderly and Adult Patients.

Age-Related Differences in Vancomycin-Associated Nephrotoxicity and Efficacy in Methicillin-Resistant Staphylococcus aureus Infection: A Comparative Study between Elderly and Adult Patients.

Journal: Antibiotics (Basel, Switzerland)

Published: February 20, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026